OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial

HTML

Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Respiratory Medicine
DOI: 10.1016/s2213-2600(18)30181-4
Authors: Toby M Maher, Ellen M van der Aar, Olivier Van de Steen, Lisa Allamassey, Julie Desrivot, Sonia Dupont, Liesbeth Fagard, Paul Ford, Ann Fieuw, Wim Wuyts
Institutions: Royal Brompton Hospital, Imperial College London, Galapagos (Belgium), Galapagos (France), Universitair Ziekenhuis Leuven
Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: autotaxin inhibitors, idiopathic pulmonary fibrosis, lysophosphatidic acid, safety and tolerability, pharmacokinetics, pharmacodynamics, lung function decline, treatment-emergent adverse events, bronchoalveolar lavage fluid, pirfenidone
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2804526434
FWCI: 22.08
Cites: 22
Cited by: 258
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms